| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $7,217,294 ) (Continued on the next page) |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AI165644 | Impact of intra-host population structure on influenza virus antigenic evolution | 000 | 4 | NIH | 11/11/2024 | $385,206 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AI072435 | Characterization of Lamprey B cells and Antibodies | 000 | 18 | NIH | 11/5/2024 | $519,925 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01ES033603 | Gene-Environment interactions in Autism | 000 | 4 | NIH | 11/1/2024 | $597,955 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31CA278008 | The role of DPF2 stability in SMARCB1-deficient cancers | 000 | 2 | NIH | 11/1/2024 | $48,974 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01DC021478 | Dissecting the first layer of central taste processing in Drosophila | 000 | 2 | NIH | 11/1/2024 | $341,246 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CA281148 | Targeting PGC1β/PPARγ axis for overcoming acquired resistant to third generation EGFR-TKIs | 000 | 2 | NIH | 11/6/2024 | $436,031 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AG072756 | Diversity Supplement to AG072756 | 000 | 3 | NIH | 11/7/2024 | $26,260 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AI166305 | Deep spatial immune profiling of granulomas and M. tuberculosis adaptation to disease and treatment | 001 | 4 | NIH | 11/6/2024 | $95,603 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AI166305 | Deep spatial immune profiling of granulomas and M. tuberculosis adaptation to disease and treatment | 000 | 4 | NIH | 11/5/2024 | $1,120,958 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | U24ES028507 | Enriching the Rhode Island Child Health Study | 001 | 8 | NIH | 11/8/2024 | $49,564 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | U24ES028507 | Enriching the Rhode Island Child Health Study | 000 | 8 | NIH | 11/7/2024 | $150,729 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CA276135 | Discovery of a novel MDM2-tubulin signaling pathway as a therapeutic target in AML | 000 | 2 | NIH | 11/7/2024 | $484,366 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01ES027859 | Mechanisms of transgenerational epigenetic inheritance | 000 | 8 | NIH | 10/29/2024 | $503,096 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | K22CA266739 | Revealing the cis-Regulatory Function of IMiDs in Multiple Myeloma”. | 000 | 3 | NIH | 11/6/2024 | $187,448 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CA277686 | Dissecting and targeting oncogenic functions of PAK4 in high-risk rhabdomyosarcoma | 000 | 3 | NIH | 11/15/2024 | $321,082 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01ES032440 | Interaction of Pyrethroid Exposure and the Microbiome on Parkinson's Disease related Pathologies | 000 | 4 | NIH | 11/15/2024 | $347,180 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31AI179181 | Multidisciplinary studies on overcoming SARS-CoV-2 main protease drug resistance and on fitness costs | 000 | 1 | NIH | 11/15/2024 | $48,974 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | UM1AI069418 | Emory-CDC CTU | 000 | 19 | NIH | 11/13/2024 | $223,828 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | UM1AI069418 | Emory-CDC CTU | 000 | 19 | NIH | 11/13/2024 | $1,631,995 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R21MH139049 | Integrating Loneliness and Social Isolation Insights into Late-Life Suicide Risk Prediction Through the Digital Phenotyping of Electronic Health Records | 000 | 1 | NIH | 11/13/2024 | $247,894 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R21NS132010 | Circadian rhythm regulation of blood-brain barrier transport and inflammation | 000 | 2 | NIH | 11/13/2024 | $234,750 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AI172452 | Mechano-ID for tagging immune cells | 000 | 3 | NIH | 11/14/2024 | $369,822 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31AG086006 | Interneuron dysfunction and the emergence of tau pathology in early Alzheimer’s disease | 000 | 2 | NIH | 11/14/2024 | $48,974 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AI167724 | Optimizing AAV delivery of bNAbs for HIV prevention | 000 | 4 | NIH | 11/6/2024 | $881,378 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R21AI180610 | Enhancing memory T cell defense in the female reproductive tract. | 000 | 2 | NIH | 10/30/2024 | $189,756 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R13AI189261 | HIV-DART 2024 | 000 | 1 | NIH | 11/8/2024 | $30,000 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01GM144729 | Acylations: a novel pathway in the response to mitochondrial energy dysfunction | 000 | 4 | NIH | 11/13/2024 | $281,700 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31HL168949 | Roles for integrins in control of lung barrier function | 000 | 2 | NIH | 11/8/2024 | $48,974 |
| | 2025 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | K12ES033593 | Pediatric and Reproductive Environmental Health Scholars Southeastern Environmental Exposures and Disparities (PREHS SEED) Program | 000 | 4 | NIH | 11/1/2024 | $485,301 |
| | 2025 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | NU2HJG000002 | Advancing National Public Health Institutes through the Global Network - 2024 | 01 | 1 | CDC | 11/19/2024 | $0 |
| | 2025 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | NU2HJG000002 | Advancing National Public Health Institutes through the Global Network - 2024 | 01 | 1 | CDC | 11/19/2024 | $0 |
| | 2025 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | NU2HJG000002 | Advancing National Public Health Institutes through the Global Network - 2024 | 01 | 1 | CDC | 11/19/2024 | $0 |
| | 2025 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | GE153305 | Community Project Funding/Congressionally Directed Spending - Non-Construction | 01 | 1 | HRSA | 10/23/2024 | $0 |
| | 2025 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | NU38FT000001 | Emory Center for Infectious Disease Modeling & Analytics and Training Hub (CIDMATH) | 08 | 1 | CDC | 10/10/2024 | $0 |
| | 2025 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CE003580 | RFA-CE-23-004: Youth Participatory Action Research to Prevent Community Violence among Black youth | 01 | 2 | CDC | 10/31/2024 | $0 |
| | 2025 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R21NS132071 | Development and validation of a viral vector for targeted inhibition of DG granule cells | 000 | 2 | NIH | 11/14/2024 | $0 |
| | 2025 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | G2846273 | Rural Communities Opioid Response Program ? Mental and Behavioral Health | 01 | 3 | HRSA | 10/10/2024 | $0 |
| | 2025 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | U54CK000601 | RFA-CK-20-004: Prevention Epicenter of Emory and Collaborating Healthcare Facilities (PEACH II) | 03 | 4 | CDC | 10/25/2024 | $0 |
| | 2025 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | U54CK000601 | RFA-CK-20-004: Prevention Epicenter of Emory and Collaborating Healthcare Facilities (PEACH II) | 03 | 4 | CDC | 10/25/2024 | $0 |
| | 2025 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R35GM122568 | Molecular mechanisms of ARF family GTPases | 000 | 8 | NIH | 11/8/2024 | $0 |
| | 2025 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | U3REP150549 | National Ebola Training and Education Center | 27 | 5 | ASPR | 11/19/2024 | $0 |
| | 2025 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CA283687 | Analytic diagnosis methods for disease ruling | 000 | 1 | NIH | 11/6/2024 | $0 |
| | 2025 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | K12GM000680 | IRACDA Fellowships in Research and Science Training (FIRST) | 000 | 25 | NIH | 10/28/2024 | $0 |
| | 2025 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01HL173340 | Pulmonary and pancreatic response to cystic fibrosis modulator therapy in young children | 000 | 1 | NIH | 11/7/2024 | $0 |
| | 2025 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01HL136414 | Discovery of novel mechanisms that impact CFTR translation and contribute to cystic fibrosis pathogenesis | 000 | 7 | NIH | 11/7/2024 | $0 |
| | 2025 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | RF1AG079199 | Contribution of neuromelanin to selective vulnerability of locus coeruleus neurons in Alzheimer's disease | 000 | 1 | NIH | 10/25/2024 | -$76,726 |
| | 2025 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01DK138366 | Automated Insulin Delivery for INpatients With DysGlycemia (AIDING) | 000 | 1 | NIH | 11/5/2024 | $0 |
| | 2025 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | T32GM142617 | Medical Scientist Training Program | 000 | 3 | NIH | 10/28/2024 | $0 |
| | 2025 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | U01AG088113 | Development of EP2 Receptor Antagonist to Treat Alzheimer's Disease | 000 | 1 | NIH | 10/24/2024 | $0 |
|
